Bristol-Myers Pays $75M To Settle Medicare Rebate Whistleblower Case

Mealey's (April 5, 2021, 12:09 PM EDT) -- PHILADELPHIA — Bristol-Myers Squibb Co. (BMS) has agreed to pay the United States and various states $75 million plus interest to resolve a false claims lawsuit that it knowingly underpaid Medicaid drug rebates, the U.S. attorney for the Eastern District of Pennsylvania said in an April 1 press release....

Related Sections